The anticarcinogenic properties of RBM10 are achieved in part by blocking MDM2-mediated ubiquitination and p53 degradation, and it has also been shown to inhibit tumor growth and proliferation by selectively altering selective splicing [13]. The gene discussed is RBM10; the disease is neoplasm.